Business Wire

SunOpta Announces First Quarter 2022 Financial Results

Revenue growth of 15.7% vs prior year Sequential revenue growth of 17.6% and gross profit growth of 52.1% Strong quarterly year over year revenue, gross profit and EBITDA growth expected for the balance of the year Major capacity expansion projects on

More

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50 million or approximately CAD $1.30 per share with only 38.4 million shares issued Profit realized on the sale of the non-core asset which was acquired by

More

Domain Therapeutics Raises $42m Series A Financing

To accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs STRASBOURG, France & MONTREAL--(BUSINESS WIRE)--Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovativ

More

AbCellera Reports Q1 2022 Business Results

Total revenue of $317 million, compared to $203 million in Q1 2021 Six program starts in the quarter bringing cumulative total to 84, up 56% from Q1 2021 Net earnings of $0.59 per share on a basic and $0.54 on a diluted basis compared to $0.43 (bas

More

AGI Announces First Quarter 2022 Results

WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) today announced its financial results for the three-months ended March 31, 20221. [thousands of dollars except per share

More